Recent Study: Angina (Angina Pectoris) Global Clinical Trials Review, H2, 2013
This report provides elemental information and data relating to the clinical trials on Angina .
Recognizing Heart Attack and Angina
Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.
Journal of Human Hypertension
Calcium channel blocker-induced gingival enlargement
Correspondence: Dr R Livada, Department of Periodontology, College of Dentistry, University of Tennessee Health Center, 875 Union Avenue, Memphis, TN 38163, USA.
Gilead Sciences, Inc. Uses the PHT Corporation LogPad System for 1st...
World's most widely used ePRO System leveraged on 14-country, 104-site, 927-patient trial; primary and secondary endpoints achieved, with 98% patient compliance )--The PHT Corporation LogPadA System was used by Gilead Sciences, Inc. on the Phase 4 TERISA trial which measured the antianginal effect of Ranolazine in T2DM patients in the therapeutic ... (more)
Ventrus Biosciences Completes Enrollment of Second Pivotal Phase 3...
Ventrus Biosciences, Inc. announced that it has completed patient enrollment and randomization in the second Phase 3 clinical trial of Diltiazem Hydrochloride 2% Cream in patients with pain related to anal fissure .
Among patients with recent ACS, use of enzyme inhibitor does not reduce risk of cardiovascular event
Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia, and colleagues determined the effects of varespladib, a drug that inhibits the enzyme secretory phospholipase A2 on cardiovascular risk in patients with acute coronary syndrome .
Heart care group revises bad cholesterol guidelines to help lower stroke risks
More Americans should take cholesterol-lowering medication, according to new guidelines by the American Heart Association.
UCLA physicians treat angina patients with stem cells
Standing from left to right: Dr. Jonathan Tobis, Marty Greenfield, Dr. Rubine Gevorgyan and Dr. William Suh.